Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

There can be little doubt that 2006 turned out to be the annus horribilis for therapeutic cloning by somatic nuclear transfer (SNT). As the full extent of the fraud surrounding the generation of patient-specific embryonic stem (ES) cell lines became apparent, hopes began to fade for the advent of cell replacement therapies (CRT), free from the confounding issues of immune rejection. While the dust begins to settle, it is perhaps pertinent to ask whether the promise of SNT is still worth pursuing or whether alternative strategies for immune evasion might help fill the void.

Original publication

DOI

10.1016/j.coi.2007.07.010

Type

Journal article

Journal

Curr Opin Immunol

Publication Date

10/2007

Volume

19

Pages

596 - 602

Keywords

Animals, Embryonic Stem Cells, Humans, Nuclear Transfer Techniques, Pluripotent Stem Cells, Stem Cell Transplantation, Transplantation Tolerance